The Dialysis Patient and Transplantation

  • Ulrich Frei


The availability of regular dialysis as renal replacement therapy is not only an essential prerequisite for the performance of renal transplantation but also still offers the sole possibility of survival for a large percentage of patients with end-stage renal disease. The rising cost of keeping the steadily growing population of patients with endstage renal disease alive by regular dialysis challenges the health economies and the commitments of even the developed countries. Renal transplantation offers the potential to slow this cost explosion and to eventually stabilize the population on regular dialysis as well as to provide the best personal rehabilitation in the treatment of terminal renal failure (1). The consequence therefore is to offer the chance of renal transplantation to each suitable dialysis patient as substantial part of an integrated treatment framework. Unfortunately this possibility is only a theoretical one because of the limited availability of suitable organs for transplantation in most countries. Religious, social, political and educational constraints do not allow to use all available cadaver donors or to perform transplants from living related or unrelated donors


Graft Survival Renal Allograft Transplant Proc Chronic Rejection Nephrol Dial Transplant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Koch KM, Halloran PF: Dialysis and transplantation. (Editorial) Curr Opin Nephrol Hypertens 1: 3, 1992CrossRefGoogle Scholar
  2. 2.
    Singer PA: A review of public policies to procure and distribute kidneys for transplantation. Arch Intern Med 150: 523, 1990PubMedCrossRefGoogle Scholar
  3. 3.
    Groenewoud AF, Persijn GG, Hendriks GF, D’Amaro J, Cohen B: Influence of HLA matching, donor age, and cyclosporine on unrelated pediatric renal allograft survival. Transplant Proc 19: 699, 1987Google Scholar
  4. 4.
    Ellison MD, Breen TJ, Guo TG, Cunningham PR, Daily OP: Blacks and whites on the UNOS renal waiting list: waiting times and patient demographics compared. Transplant Proc 25: 2462, 1993PubMedGoogle Scholar
  5. 5.
    Edwards EB, Guo T, Breen TJ, Bowen GR, Daily OP: The UNOS OPTN waiting list from 1988 to 1993. Clin Transpl 71, 1993Google Scholar
  6. 6.
    Ramos EL, Kasiske BL, Alexander SR, Danovitch GM, Harmon WE, Kahana L et al.: The evaluation of candidates for renal transplantation. The current practice of US transplant centers. Transplantation 57: 490, 1994PubMedCrossRefGoogle Scholar
  7. 7.
    Rosenthal JT: Expanded criteria for cadaver organ donation in renal transplantation. Urol Clin North Am 21: 283, 1994PubMedGoogle Scholar
  8. 8.
    Creagh TA, McLean PA, Donovan MG, Walshe JJ, Murphy DM: Older donors and kidney transplantation. Transpl Int 6: 39, 1993PubMedCrossRefGoogle Scholar
  9. 9.
    Rao KV, Kasiske BL, Odlund MD, Ney AL, Andersen RC: Influence of cadaver donor age on posttransplant renal function and graft outcome. Transplantation 49: 91, 1990PubMedGoogle Scholar
  10. 10.
    Foster MC, Wenham PW, Rowe PA, Blarney RW, Bishop MC, Burden RP et al.: Use of older patients as cadaveric kidney donors. Br J Surg 75: 767, 1988PubMedCrossRefGoogle Scholar
  11. 11.
    Ploeg RJ, Visser MJ, Stijnen T, Persijn GG, van Schilfgaarde: Impact of donor age and quality of donor kidneys on graft survival. Transplant Proc 19: 1532, 1987PubMedGoogle Scholar
  12. 12.
    Orloff MS, Reed AI, Erturk E, Kruk RA, Paprocki SA, Cimbalo SC et al.: Nonheartbeating cadaveric organ donation. Ann Surg 220: 578, 1994PubMedGoogle Scholar
  13. 13.
    Terasaki PI, Koyama H, Cecka JM, Gjertson DW: The hyperfiltration hypothesis in human renal transplantation. Transplantation 57: 1450, 1994PubMedCrossRefGoogle Scholar
  14. 14.
    Ratner LE, Joseph V, Zibari G, Patel S, Maley WR, Kittur D et al.: Transplantation of kidneys from hypertensive cadaveric donors. Transplant Proc 27: 989, 1995PubMedGoogle Scholar
  15. 15.
    Kalayoglu M, Sollinger HW, Stratta RJ, D’Alessandro AM, Hoffmann RM, Pirsch JD et al.: Extended preservation of the liver for clinical transplantation. Lancet 1: 617, 1988PubMedGoogle Scholar
  16. 16.
    Ploeg RJ, Goossens D, Vreugdenhil P, McAnulty JF, Southard JH, Beizer FO: Successful 72-hour cold storage kidney preservation with UW solution. Transplant Proc 20: 935, 1988PubMedGoogle Scholar
  17. 17.
    Kallerhoff M, Blech M, Kehrer G, Kleinen H, Siekmann W, Helmchen U et al.: Post-ischemic renal function after kidney protection with the HTK-solution of Bretschneider. Urol Res 14:271, 1986PubMedCrossRefGoogle Scholar
  18. 18.
    Frei U, Margreiter R, Harms A, Bosmuller C, Neumann KH, Viebahn R et al.: Preoperative graft reperfusion with a calcium antagonist improves initial function: preliminary results of a prospective randomized trial in 110 kidney recipients. Transplant Proc 19: 3539, 1987PubMedGoogle Scholar
  19. 19.
    Neumayer HH, Kunzendorf U, Schreiber M: Protective effects of diltiazem and the prostazycline analogue iloprost in human renal transplantation. Ren Fail 14: 289, 1992PubMedCrossRefGoogle Scholar
  20. 20.
    Klein HG, Dimitrov D, Atanasova I, Hohenfellner RM, Schmausser U, Natcheff N et al.: Atrial natriuretic factor infusion following acute renal ischemia in anesthetized dogs. Renal Physiol Biochem 15: 73, 1992PubMedGoogle Scholar
  21. 21.
    Almond PS, Gillingham KJ, Sibley R, Moss A, Melin M, Leventhal J et al.: Renal transplant function after ten years of cyclosporine. Transplantation 53: 316, 1992PubMedGoogle Scholar
  22. 22.
    Kliem V, Ringe B, Holhorst K, Frei U: Kidney transplantation in hepatitis B surface antigen carriers. Clin Investig 72: 1000, 1994PubMedCrossRefGoogle Scholar
  23. 23.
    Kasiske BL, Ramos EL, Gaston RS, Bia MJ, Danovitch GM, Bowen PA et al.: The evaluation of renal transplant candidates: Clinical Practice Guidelines. J Am Soc Nephrol 6: 1, 1995PubMedGoogle Scholar
  24. 24.
    Cameron JS: Recurrent disease in renal allografts. Kidney Int 43(Suppl):S91, 1993Google Scholar
  25. 25.
    Ramos EL, Tisher CC: Recurrent diseases in the kidney transplant. Am J Kidney Dis 24: 142, 1994PubMedGoogle Scholar
  26. 26.
    Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F: Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 92: 375, 1992PubMedCrossRefGoogle Scholar
  27. 27.
    Tejani A, Stablein DH: Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 2: S258, 1992Google Scholar
  28. 28.
    Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jacques Y et al.: Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 330: 7, 1994PubMedCrossRefGoogle Scholar
  29. 29.
    Li PK, Lai FM, Leung CB, Lui SF, Wang A, Lai KN: Plasma exchange in the treatment of early recurrent focal glomerulosclerosis after renal transplantation. Report and review. Am J Nephrol 13: 289, 1993PubMedCrossRefGoogle Scholar
  30. 30.
    Soderdahl G, Tyden G, Groth CG: Incidence of gastrointestinal complications following renal transplantation in the cyclosporin era. Transplant Proc 26: 1771, 1994PubMedGoogle Scholar
  31. 31.
    Benoit G, Moukarzel M, Verdelli G, Hiesse C, Buffet C, Bensadoun H et al.: Gastrointestinal complications in renal transplantation. Transpl Int 6: 45, 1993PubMedCrossRefGoogle Scholar
  32. 32.
    Kasiske BL: Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 84: 985, 1988PubMedCrossRefGoogle Scholar
  33. 33.
    Braun WE: Long-term complications of renal transplantation (clinical conference). Kidney Int 37: 1363, 1990PubMedCrossRefGoogle Scholar
  34. 34.
    Reis G, Marcovitz PA, Leichtman AB, Merion RM, Fay WP, Werns SW et al.: Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease. Am J Cardiol 75: 707, 1995PubMedCrossRefGoogle Scholar
  35. 35.
    Burt RK, Gupta-Burt S, Suki WN, Barcenas CG, Ferguson JJ, Van Buren C: Reversal of left ventricular dysfunction after renal transplantation. Ann Intern Med 111: 635, 1989PubMedGoogle Scholar
  36. 36.
    Penn I: Effect of immunosuppression on preexisting cancers. Transplant Proc 25: 1380, 1993PubMedGoogle Scholar
  37. 37.
    Thorogood J, van Houwelingen JC, Persijn GG, Van Rood JJ: The contribution of failure time of first kidney graft to predicting failure of regrafts. Transplant Proc 22: 15, 1990Google Scholar
  38. 38.
    Taube D: Immunoadsorption in the sensitized transplant recipient (clinical conference). Kidney Int 38: 350, 1990PubMedCrossRefGoogle Scholar
  39. 39.
    Rankin GW Jr, Wang XM, Terasaki PI: Sensitization to kidney transplants. Clin Transpl 417, 1990Google Scholar
  40. 40.
    Cecka JM, Gjertson DW, Cho Y, Terasaki PI: HLA polymorphisms, ethnicity, and graft survival: united network for organ sharing. UNOS Scientific Renal Transplant Registry. Transplant Proc 25: 2446, 1993PubMedGoogle Scholar
  41. 41.
    Gaston RS, Shroyer TW, Hudson SL, Deierhoi MH, Laskow DA, Barber WH et al.: Renal retransplantation: the role of race, quadruple immunosuppression, and the flow cytometry cross-match. Transplantation 57: 47, 1994PubMedCrossRefGoogle Scholar
  42. 42.
    Sketris IS, Methot ME, Nicol D, Belitsky P, Knox MG: Effect of calcium-channel blockers on cyclosporine clearance and use in renal transplant patients. Ann Pharmacother 28: 1227, 1994PubMedGoogle Scholar
  43. 43.
    Sorenson AL, Lovdahl M, Hewitt JM, Granger DK, Almond PS, Russlie HQ et al.: Effects of ketoconazole on cyclosporine metabolism in renal allograft recipients. Transplant Proc 26: 2822, 1994PubMedGoogle Scholar
  44. 44.
    Peschke B, Ernst W, Gossmann J, Kachel HG, Schoeppe W, Scheuermann EH: Antituberculous drugs in kidney transplant recipients treated with cyclosporine. Transplantation 56: 236, 1993PubMedCrossRefGoogle Scholar
  45. 45.
    Tesi RJ, Elkhammas EA, Davies EA, Henry ML, Ferguson RM: Renal transplantation in older people. Lancet 343:461, 1994PubMedCrossRefGoogle Scholar
  46. 46.
    Velez RL, Brinker KR, Vergne-Marini PJ, Nesser DA, Long DL, Trevino G et al.: Renal transplantation with cyclosporine in the elderly population. Transplant Proc 23: 1749, 1991PubMedGoogle Scholar
  47. 47.
    Kalil RS, Heim-Duthoy KL, Kasiske BL: Patients with a low income have reduced renal allograft survival. Am J Kidney Dis 20: 63, 1992PubMedGoogle Scholar
  48. 48.
    Sketris I, Waite N, Grobler K, West M, Gerus S: Factors affecting compliance with cyclosporine in adult renal transplant patients. Transplant Proc 26: 2538, 1994PubMedGoogle Scholar
  49. 49.
    Siegal BR: Postrenal transplant compliance: report of 519 responses to a self-report questionnaire. Transplant Proc 25: 2502, 1993PubMedGoogle Scholar
  50. 50.
    Kiley DJ, Lam CS, Pollak R: A study of treatment compliance following kidney transplantation. Transplantation 55:51, 1993PubMedCrossRefGoogle Scholar
  51. 51.
    Terasaki PI, Gjertson DW, Cecka JM, Takemoto S: HLA matching for improved cadaver kidney allocation. Curr Opin Nephrol Hypertens 3: 585, 1994PubMedCrossRefGoogle Scholar
  52. 52.
    Braun WE: Allocation of cadaver kidneys: newpressures, new solutions. Am J Kidney Dis 24: 526, 1994PubMedGoogle Scholar
  53. 53.
    Cohen DJ, Benvenisty AI, Benstein JA, Reed EF, Ho E, Suciu-Foca N et al.: Influence of HLA matching on kidney allograft survival: UNOS allocation system greatly improves the outcome. Transplant Proc 27: 805, 1995PubMedGoogle Scholar
  54. 54.
    Takemoto S, Terasaki PI, Gjertson DW, Cecka JM: Equitable allocation of HLA-compatible kidneys for local pools and minorities. N Engl J Med 331: 760, 1994PubMedCrossRefGoogle Scholar
  55. 55.
    Yuan Y, Gafni A, Russell JD, Ludwin D: Development of a central matching system for the allocation of cadaveric kidneys: a simulation of clinical effectiveness versus equity. Med Decis Making 14: 124, 1994PubMedCrossRefGoogle Scholar
  56. 56.
    Davies DB, Breen TJ, Guo T, Ellison MD, Daily OP, Harmon WE: Waiting times to pediatric transplantation: an assessment of the August 1990 change in renal allocation policy. Transplant Proc 26: 30, 1994PubMedGoogle Scholar
  57. 57.
    Matas AJ: Is MHC matching as a primary criterion in kidney allocation justified? (News) Nat Genet 5: 210, 1993PubMedCrossRefGoogle Scholar
  58. 58.
    Gaston RS, Ayres I, Dooley LG, Diethelm AG: Racial equity in renal transplantation. The disparate impact of HLA-based allocation (see comments). JAMA 270: 1352, 1993PubMedCrossRefGoogle Scholar
  59. 59.
    Sanfilippo F: Organ allocation: current problems and future issues. Transplant Proc 25: 2467, 1993PubMedGoogle Scholar
  60. 60.
    Rosenberg JC, Beyersdorf TM, Derbyshire N, Fortunate R, Manley G, Williams T: Retrieval and allocation of organs for transplantation: the Michigan experience. Clin Transpl 335, 1993Google Scholar
  61. 61.
    Lazda VA: Access to the kidney donor pool for racial minority population is maximized by a variance of the UNOS point system — a regional experience. Regional Organ Bank of Illinois. Clin Transpl 325, 1993Google Scholar
  62. 62.
    Harris JS, De Lone PA: Allocation of cadaver kidneys. ANNA J 19: 47, 1992PubMedGoogle Scholar
  63. 63.
    Gjertson DW, Terasaki PI, Takemoto S, Mickey MR: National allocation of cadaveric kidneys by HLA matching. Projected effect on outcome and costs. N Engl J Med 324: 1032, 1991PubMedCrossRefGoogle Scholar
  64. 64.
    Takemoto S, Terasaki PI, Cecka JM, Cho YW, Gjertson DW: Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry. N Engl J Med 327: 834, 1992PubMedCrossRefGoogle Scholar
  65. 65.
    Sanfilippo FP, Vaughn WK, Peters TG, Shield CF 3rd, Adams PL, Lorber MI, et al.: Factors affecting the waiting time of cadaveric kidney transplant candidates in the United States. JAMA 267: 247, 1992PubMedCrossRefGoogle Scholar
  66. 66.
    Wujciak T, Opelz G: A computer model for improved cadaver kidney allocation. Transplant Proc 25: 31, 1993Google Scholar
  67. 67.
    Opelz G: The benefit of exchanging donor kidneys among transplant centers. N Engl J Med 318: 1289, 1988PubMedCrossRefGoogle Scholar
  68. 68.
    Takiff H, Cook DJ, Himaya NS, Mickey MR, Terasaki PI: Dominant effect of histocompatibility on ten-year kidney transplant survival. Transplantation 45: 410, 1988PubMedGoogle Scholar
  69. 69.
    Held PJ, Kahan BD, Hunsicker LG, Liska D, Wolfe RA, Port FK et al.: The impact of HLA mismatches on the survival of first cadaveric kidney transplants. N Engl J Med 331:765, 1994PubMedCrossRefGoogle Scholar
  70. 70.
    Wyner LM, Novick AC, Streem SB, Hodge EE: Improved success of living unrelated renal transplantation with cyclosporine immunosuppression. J Urol 149: 706, 1993PubMedGoogle Scholar
  71. 71.
    Sankari BR, Wyner LM, Streem SB: Living unrelated donor renal transplantation. Urol Clin North Am 21: 293, 1994PubMedGoogle Scholar
  72. 72.
    Schulak JA, Hricik DE: Steroid withdrawal after renal transplantation. Clin Transplant 8: 211, 1994PubMedGoogle Scholar
  73. 73.
    Hricik DE, Whalen CC, Lautman J, Bartucci MR, Moir EJ, Mayes JT et al.: Withdrawal of steroids after renal transplantation — clinical predictors of outcome. Transplantation 53: 41, 1992PubMedGoogle Scholar
  74. 74.
    Terasaki PI: Overview, in: Clinical Transplants 1988, edited by Terasaki PI, Cecka JM, Takemoto S, Yuge J, Mickey MR, Park MS et al., Los Angeles, UCLA Tissue Typing Laboratory, 1988, p 409Google Scholar
  75. 75.
    Frei U, Brunkhorst R, Schindler R, Bode U, Repp H, Pichlmayr R et al.: Present status of kidney transplantation. Clin Nephrol 38(Suppl 1): S46, 1992Google Scholar
  76. 76.
    Opelz G: The benefit of exchanging donor kidneys among transplant centers. N Engl J Med 318: 1289, 1988PubMedCrossRefGoogle Scholar
  77. 77.
    Donnelly P, Veitch P, Bell P, Henderson R, Oman P, Proud G: Donor-recipient age difference — an independent risk factor in cyclosporin-treated renal transplant recipients. Transpl Int 4: 88, 1991PubMedGoogle Scholar
  78. 78.
    Donnelly PK, Simpson AR, Milner AD, Nicholson ML, Horsburgh T, Veitch PS, et al.: Age-matching improves the results of renal transplantation with older donors [see comments]. Nephrol Dial Transplant 5: 808, 1990PubMedGoogle Scholar
  79. 79.
    Soulillou JP, Cantarovich D, Le Mauff B, Giral M, Robillard N, Hourmant M et al.: Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts. N Engl J Med 322: 1175, 1990PubMedCrossRefGoogle Scholar
  80. 80.
    Frey DJ, Matas AJ, Gillingham KJ, Canafax D, Payne WD, Dunn DL et al.: MALG vs OKT3 following renal transplantation: a randomized prospective trial. Transplant Proc 23: 1048, 1991PubMedGoogle Scholar
  81. 81.
    Hoitsma AJ, Tiggeler RG, Wetzels JF, Berden JH, Koene RA: Comparison of 10-day and 21-day ATG-antirejection treatment in renal transplant patients treated with either cyclosporine or azathioprine as basic immunosuppression. Transplant Proc 21: 1732, 1989PubMedGoogle Scholar
  82. 82.
    Palmer BF, Dawidson I, Sagalowsky A, Sandor Z, Lu CY: Improved outcome of cadaveric renal transplantation due to calcium channel blockers. Transplantation 52: 640, 1991PubMedCrossRefGoogle Scholar
  83. 83.
    Hoyer PF, Offner G, Brodehl J, Ringe B, Bunzendahl H, Pichlmayr R: Renal function and donor age: five years’ experience with cyclosporin A. Transplant Proc 21: 30, 1989Google Scholar
  84. 84.
    Thorogood J, Houwelingen JC, Persijn GG, Zantvoort FA, Schreuder GM, van Rood JJ: Prognostic indices to predict survival of first and second renal allografts. Transplantation 52: 831, 1991PubMedCrossRefGoogle Scholar
  85. 85.
    Opelz G: Influence of HLA matching on survival of second kidney transplants in cyclosporine-treated recipients. Transplantation 47: 823, 1989PubMedCrossRefGoogle Scholar
  86. 86.
    Opelz G: Importance of HLA antigen splits for kidney transplant matching. Lancet 2: 61, 1988PubMedCrossRefGoogle Scholar
  87. 87.
    Opelz G, Mytilineos J, Scherer S, Dunckley H, Trejaut J, Chapman J et al.: Analysis of HLA-DR matching in DNA-typed cadaver kidney transplants. Transplantation 55: 782, 1993PubMedGoogle Scholar
  88. 88.
    Gouny P, Lenot B, Decaix B, Rondeau E, Kitzis M, Lacave R et al.: Aortoiliac surgery and kidney transplantation. Ann Vasc Surg 5: 26, 1991PubMedCrossRefGoogle Scholar
  89. 89.
    Wright JG, Tesi RJ, Massop DW, Henry ML, Durham JR, Ferguson RM et al.: Safety of simultaneous aortic reconstruction and renal transplantation. Am J Surg 162: 126, 1991PubMedCrossRefGoogle Scholar
  90. 90.
    Langle F, Muhlbacher F, Steininger R, Kovarik J, Derfler K, Balcke P et al.: Long-term outcome in renal patients beyond five years after kidney transplantation. Transplant Proc 21: 2176, 1989PubMedGoogle Scholar
  91. 91.
    Olivari M-T, Kubo SH, Braunlin EA, Bolman RM, Ring WS: Five-year experience with triple-drug immunosuppressive therapy in cardiac transplantation. Circulation 82(Suppl 4): IV276, 1990PubMedGoogle Scholar
  92. 92.
    Thorogood J, Persijn GG, Schreuder GM, D’Amaro J, Zantvoort FA, van Houwelingen JC et al.: The effect of HLA matching on kidney graft survival in separate posttransplantation intervals. Transplantation 50: 146, 1990PubMedCrossRefGoogle Scholar
  93. 93.
    Gjertson DW: Multifactorial analysis of renal transplants reported to the United Network for Organ Sharing Registry. Clin Transpl 299, 1992Google Scholar
  94. 94.
    Takiff H, Mickey MR, Cicciarelli J, Terasaki PI: Factors important in ten-year kidney graft survival. Transplant Proc 19: 666, 1987PubMedGoogle Scholar
  95. 95.
    Hall BM, Tiller DJ, Hardie I, Mahony J, Mathew T, Thatcher G et al.: Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine. N Engl J Med 318: 1499, 1988PubMedCrossRefGoogle Scholar
  96. 96.
    Vanrenterghem Y, Roels L, Lerut T, Waer M, Gruwez J, Michielsen P: Long-term prognosis after cadaveric kidney transplantation. Transplant Proc 19: 3762, 1987PubMedGoogle Scholar
  97. 97.
    Fujimori K, Satomi S, Okazaki H, Taguchi Y, Mori S: The effect of protein intake on creatinine clearance in transplanted kidneys. Transplant Proc 21: 2048, 1989PubMedGoogle Scholar
  98. 98.
    Windus DW, Lacson S, Delmez JA: The short-term effects of a low-protein diet in stable renal transplant recipients. Am J Kidney Dis 17: 693, 1991PubMedGoogle Scholar
  99. 99.
    Fabrega AJ, Lopez-Boado M, Gonzalez S: Problems in the long-term renal allograft recipient. Crit Care Clin 6: 979, 1990PubMedGoogle Scholar
  100. 100.
    Rao KV: Mechanism, pathophysiology, diagnosis, and management of renal transplant rejection. Med Clin North Am 74: 1039, 1990PubMedGoogle Scholar
  101. 101.
    Rao KV, Andersen RC: Long-term results and complications in renal transplant recipients. Observations in the second decade. Transplantation 45: 45, 1988PubMedGoogle Scholar
  102. 102.
    Rosenblum ND, Harmon WE, Levey RH: Treatment of chronic renal allograft rejection with cyclosporine and prednisone. Transplantation 45: 232, 1988PubMedGoogle Scholar
  103. 103.
    Mennander A, Tiisala S, Halttunen J, Yilmaz S, Paavonen T, Hayry P: Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis. Arterioscler Thromb 11: 671, 1991PubMedGoogle Scholar
  104. 104.
    Frei U, Schindler R, Wieters D, Grouven U, Brunkhorst R, Koch KM: Pre-transplant hypertension — a major risk factor for chronic progressive renal allograft dysfunction? Nephrol Dial Transplant 10: 1206, 1995PubMedGoogle Scholar
  105. 105.
    Wright JG, Tesi RJ, Massop DW, Henry ML, Durham JR, Ferguson RM et al.: Safety of simultaneous aortic reconstruction and renal transplantation. Am J Surg 162: 126, 1991PubMedCrossRefGoogle Scholar
  106. 106.
    Schorn TF, Frei U, Brackmann H, Lorenz M, Vogt P, Wiese B et al.: Cyclosporine-associated posttransplant hypertension incidence and effect on renal transplant function. Transplant Proc 20: 610, 1988PubMedGoogle Scholar
  107. 107.
    Isoniemi H, Tikkanen M, Hayry P, Eklund B, Hockerstedt K, Salmela K et al.: Lipid profiles with triple drug immunosuppressive therapy and with double drug combinations after renal transplantation and stable graft function. Transplant Proc 23: 1029, 1991PubMedGoogle Scholar
  108. 108.
    Schorn TF, Kliem V, Bojanovski M, Bojanovski D, Repp H, Bunzendahl H et al.: Impact of long-term immunosuppression with cyclosporin A on serum lipids in stable renal transplant recipients. Transpl Int 4: 92, 1991PubMedGoogle Scholar
  109. 109.
    Penn I: Cancer in the immunosuppressed organ recipient. Transplant Proc 23: 1771, 1991PubMedGoogle Scholar
  110. 110.
    Penn I: Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl 53, 1990Google Scholar
  111. 111.
    Cockfield SM, Preiksaitis J, Harvey E, Jones C, Hebert D, Keown P et al.: Is sequential use of ALG and OKT3 in renal transplants associated with an increased incidence of fulminant posttransplant lvmphoproliferative disorder? Transplant Proc 23: 1106, 1991PubMedGoogle Scholar
  112. 112.
    Vogt P, Frei U, Repp H, Bunzendahl H, Oldhafer K, Pichlmayr R: Malignant tumours in renal transplant recipients receiving cyclosporin: survey of 598 first-kidney transplantations. Nephrol Dial Transplant 5: 282, 1990PubMedGoogle Scholar
  113. 113.
    Walz MK, Albrecht KH, Niebel W, Eigler FW: De novo malignant tumors during drug immunosuppression. The findings following 1245 cadaveric kidney transplants in 1080 patients. Dtsch Med Wochenschr 117: 927, 1992PubMedCrossRefGoogle Scholar
  114. 114.
    Sheil AG, Disney AP, Mathew TH, Amiss N: De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant Proc 25: 1383, 1993PubMedGoogle Scholar
  115. 115.
    Frei U, Bode U, Repp H, Schindler R, Brunkhorst R, Vogt P et al.: Malignancies under cyclosporine after kidney transplantation: analysis of a 10-year period. Transplant Proc 25: 1394, 1993PubMedGoogle Scholar
  116. 116.
    Pol S, Debure A, Degott C, Carnot F, Legendre C, Brechot C et al.: Chronic hepatitis in kidney allograft recipients. Lancet 335: 878, 1990PubMedCrossRefGoogle Scholar
  117. 117.
    Parfrey PS et al.: The impact of transplantation on the course of hepatitis B liver disease. Transplantation 39: 610, 1985PubMedCrossRefGoogle Scholar
  118. 118.
    Toussaint C, Kinnaert P, Vereerstraeten P: Late mortality and morbidity five to eighteen years after kidney transplantation. Transplantation 45: 554, 1988PubMedCrossRefGoogle Scholar
  119. 119.
    Rao KV, Kasiske BL, Anderson WR: Variability in the morphological spectrum and clinical outcome of chronic liver disease in hepatitis B-positive and B-negative renal transplant recipients. Transplantation 51: 391, 1991PubMedGoogle Scholar
  120. 120.
    Kiberd BA, Belitsky P: The fate of the failed renal transplant. Transplantation 59: 645, 1995PubMedGoogle Scholar
  121. 121.
    Almond MK, Tailor D, Marsh FP, Raftery MJ, Cunningham J: Increased erythropoietin requirements in patients with failed renal transplants returning to a dialysis programme. Nephrol Dial Transplant 9: 270, 1994PubMedGoogle Scholar
  122. 122.
    Cattran DC, Fenton SS: Contemporary management of renal failure: outcome of the failed allograft recipient. Kidney Int 41(Suppl): S36, 1993Google Scholar
  123. 123.
    Hansen BL, Rohr N, Svendsen V, Birkeland SA: Graft failure and graft nephrectomy without severe complications. Nephrol Dial Transplant 2: 189, 1987PubMedGoogle Scholar
  124. 124.
    Verresen L, Vanrenterghem Y, Waer M, Hauglustaine D, Michielsen P: Corticosteroid withdrawal syndrome in dialysis patients. Nephrol Dial Transplant 3: 476, 1988PubMedGoogle Scholar
  125. 125.
    Ramos EL: Recurrent diseases in the renal allograft. J Am Soc Nephrol 2: 109, 1991PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Ulrich Frei
    • 1
  1. 1.Medical Clinic and Policlinic Department of Internal Medicine and NephrologyVirchow-Klinikum of Humboldt-UniversityBerlinGermany

Personalised recommendations